Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<1% 5% <5% <2% <2%
General Information
Version
1.3
Revision date
2025-01-03
Product name
Lymphosep, Lymphocyte Separation Media
CAS No.
1310-73-2
1.2.2. Uses advised against
The product, as such or as a component of a mixture, is not intended to be used by consumers (as defined by the REACH Regulation)
Emergency telephone
+44 (0) 1270 502894
Icons in SDS
Company Information
company name
VWR International Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@avantorsciences.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.2 Label elements
2.2.1 Labelling
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation.
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection/face protection. P264 Wash hands thoroughly after handling. P302+P352 IF ON SKIN: Wash with plenty of water. P362+P364 Take off contaminated clothing and wash it before reuse. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see FIRST AID on this label). P332+P313 If skin irritation occurs: Get medical advice/attention.
2.3 Other hazards
The substances in the mixture do not meet the PBT/vPvB criteria according to REACH, annex XIII. This product does not contain a substance that has endocrine disrupting properties.
